Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.
De Ferrari GM, Maier LS, Mont L, Schwartz PJ, Simonis G, Leschke M, Gronda E, Boriani G, Darius H, Guillamón Torán L, Savelieva I, Dusi V, Marchionni N, Quintana Rendón M, Schumacher K, Tonini G, Melani L, Giannelli S, Alberto Maggi C, Camm AJ; RAFFAELLO Investigators (see Online Supplementary Appendix for List of Participating Centers and Investigators). De Ferrari GM, et al. Among authors: leschke m. Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17. Heart Rhythm. 2015. PMID: 25602175 Clinical Trial.
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV; GLORIA-AF Investigators. Lip GYH, et al. Clin Res Cardiol. 2022 May;111(5):593. doi: 10.1007/s00392-022-02021-2. Clin Res Cardiol. 2022. PMID: 35384487 Free PMC article. No abstract available.
The 'all comer' Coroflex Please drug-eluting stent registry in Europe and Asia - an overall and transcontinental assessment of the 10-month major adverse cardiac events.
Leschke M, Nhan VT, Waliszewski M, Palacios V, Horváth I, Ivanov VA, Tresukosol D, Avraamides P, Schneider A, Unverdorben M. Leschke M, et al. Indian Heart J. 2012 Sep-Oct;64(5):453-61. doi: 10.1016/j.ihj.2012.08.002. Epub 2012 Aug 27. Indian Heart J. 2012. PMID: 23102382 Free PMC article.
Thin strut bare metal stents in patients with atrial fibrillation: Is there still a need for BMS?
Leschke M, Waliszewski M, Pons M, Champin S, Nait Saidi L, Mok Heang T, Maskon O, Azman Bin Wan Ahmad W, Herberger D, Moulichon ME, Rischner J, Robin C, Leclercq F, Peyre JP, Faurie B, Schneider A. Leschke M, et al. Catheter Cardiovasc Interv. 2016 Sep;88(3):358-66. doi: 10.1002/ccd.26261. Epub 2015 Dec 9. Catheter Cardiovasc Interv. 2016. PMID: 26650913
Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture.
Krackhardt F, Rosli MA, Leschke M, Schneider A, Sperling C, Heang TM, Pons M, Sousa PJ, Kherad B, Waliszewski M. Krackhardt F, et al. Among authors: leschke m. Catheter Cardiovasc Interv. 2018 Jun;91(7):1221-1228. doi: 10.1002/ccd.27306. Epub 2017 Sep 25. Catheter Cardiovasc Interv. 2018. PMID: 28944613
157 results